Cancer is one of the most prevalent diseases worldwide, which causes significant morbidity and mortality. Designing and developing a potential anti-cancer drug is an active field of research worldwide. Microorganisms have been considered a potential source of anti-cancer drugs. One such microbe-derived compound is surfactin, which shows potential anti-cancer activities. In this study, we evaluated the binding potential of surfactin with several cancer cell ligands via an in-silico approach. Hence, molecular docking studies were performed to test the binding potential of surfactin against four targets. The analyses revealed that surfactin from Bacillus sp. can bind with the targeted ligands (coenzyme A, D-leucine, glycerol, and (R)-3-hydroxytetradecanal) with significant affinity. Surfactin showed the highest binding affinity (-7.7 kcal mol-1) to coenzyme A among the targeted ligands. These results may be useful for developing anti-cancer drugs. Nevertheless, further experimental studies are needed to investigate the ligand binding capacity and anti-cancer potential of such surfactin-like molecules.
Dan AK, Manna A, Ghosh S, et al., 2021, Molecular Mechanisms of the Lipopeptides from Bacillus subtilis in the Apoptosis of Cancer Cells – A Review on its Current Status in Different Cancer Cell Lines. Adv Cancer Biol – Metastasis, 3: 100019. https://linkinghub.elsevier.com/retrieve/pii/S266739 4021000198
Harimurti S, Widada H, Arsito PN, et al., 2022, Molecular Docking for Evaluation of Piperine Affinity to the Colon Cancer Receptor. KnE Med, 2022: 472–479. https://knepublishing.com/index.php/KnE-Medicine/article/view/11900
Vaishnav N, Khare N, Katariya PK, et al., 2020, To Study the Effect of Harmine Against DNMT1 for the Treatment of Cervical Cancer Through Molecular Docking Studies. International Journal of Pharmacy and Biological Science, 10(3): 125–132.
Falzone L, Salomone S, Libra M, 2018, Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium. Front Pharmacol, 9: 1–26. https://www.frontiersin.org/article/10.3389/fph ar.2018.01300/full
Pham TH, Nguyen HN, Le TTH, 2018, In Silico Screening, Design and Synthesis of Novel Inhibitors against Histone Deacetylase (HDAC). VNU J Sci Med Pharm Sci, 34(1): 20. https://js.vnu.edu.vn/MPS/article/view/4100
Kaur B, Rolta R, Salaria D, et al., 2022, An In Silico Investigation to Explore Anti-Cancer Potential of Foeniculum vulgare Mill. Phytoconstituents for the Management of Human Breast Cancer. Molecules, 27(13): 4077. https://www.mdpi.com/1420-3049/27/13/4077
Khalid I, Jafar TH, Unar A, et al., 2021, In-Silico Identification of Anticancer Compounds; Ligand-Based Pharmacophore Approach Against EGFR Involved in Breast Cancer. Adv Breast Cancer Res, 10(03): 120–132. https://www.scirp.org/journal/doi.aspx?doi=10.4236/abcr.2021.103010
Ferdous UT, Shishir MA, Khan SN, et al., 2018, Bacillus spp.: Attractive Sources of Anti-Cancer and Anti-Proliferative Biomolecules. Microb Bioact, 1(1): E033–E045. https://doi.org/10.25163/microbb ioacts.11005B0408130818
Jujjavarapu SE, Dhagat S, 2018, In Silico Discovery of Novel Ligands for Antimicrobial Lipopeptides for Computer-Aided Drug Design. Probiotics Antimicrob Proteins, 10(2): 129–141. http://link.springer.com/10.1007/s12602-017-9356-9
Jujjavarapu SE, Dhagat S, Kurrey V, 2018, Identification of Novel Ligands for Therapeutic Lipopeptides: Daptomycin, Surfactin and Polymyxin. Curr Drug Targets, 19(13): 1589–1598. http://www.eurekaselect.com/157849/article
Wu Y-SS, Ngai S-CC, Goh B-HH, et al., 2017, Anticancer Activities of Surfactin and Potential Application of Nanotechnology Assisted Surfactin Delivery. Front Pharmacol, 8: 761. http://www.ncbi.nlm.nih.gov/pubmed/29123482
Vo TTT, Wee Y, Cheng H, Wu C, et al., 2023, Surfactin Induces Autophagy, Apoptosis, and Cell Cycle Arrest in Human Oral Squamous Cell Carcinoma. Oral Dis, 29(2): 528–541. https://onlinelibrary.wiley.com/doi/10.1111/odi.13950
Fayed MAA, El-Behairy MF, Abdallah IA, et al., 2021, Structure- and Ligand-Based In Silico Studies towards the Repurposing of Marine Bioactive Compounds to Target SARS-CoV-2. Arab J Chem, 14(4): 103092. https://linkinghub.elsevier.com/retrieve/pii/S1878535221001076
Braz HLB, Silveira JA de M, Marinho AD, et al., 2020, In Silico Study of Azithromycin, Chloroquine and Hydroxychloroquine and Their Potential Mechanisms of Action Against SARS-CoV-2 infection. Int J Antimicrob Agents, 56(3): 106119. https://linkinghub.elsevier.com/retrieve/pii/S0924857920303 022
Ahsan Z, Khare N, Jha AK, et al., 2020, The Discovery of Potential Dnmt1 Inhibitors: A Combination of Virtual Screening and Molecular Docking Studies. Int J Res Trends Innov, 5(10): 17–22.
Vo TTT, Lee C-W, Wu C-Z, et al., 2020, Surfactin from Bacillus subtilis Attenuates Ambient Air Particulate Matter-Promoted Human Oral Cancer Cells Metastatic Potential. J Cancer, 11(20): 6038–6049. https://www.jcancer.org/v11p6038.htm
Niode NJ, Adji A, Rimbing J, et al., 2021, In Silico and In Vitro Evaluation of the Antimicrobial Potential of Bacillus cereus Isolated from Apis dorsata Gut Against Neisseria gonorrhoeae. Antibiotics, 10(11): 1401. https://www.mdpi.com/2079-6382/10/11/1401
Sen R, 2010, Surfactin: Biosynthesis, Genetics and Potential Applications, in Biosurfactants Advances in Experimental Medicine and Biology, Springer, New York, 316–323.
Hasegawa Y, Takahashi M, Ariki S, et al., 2017, Surfactant Protein A Down-Regulates Epidermal Growth Factor Receptor by Mechanisms Different from Those of Surfactant Protein D. J Biol Chem, 292(45): 18565–18576.
Bonmatin J-M, Laprevote O, Peypoux F, 2012, Diversity Among Microbial Cyclic Lipopeptides: Iturins and Surfactins. Activity-Structure Relationships to Design New Bioactive Agents. Comb Chem High Throughput Screen, 6(6): 541–556.
Liu X, Tao X, Zou A, et al., 2010, Effect of the Microbial Lipopeptide on Tumor Cell Lines: Apoptosis Induced by Disturbing the Fatty Acid Composition of Cell Membrane. Protein Cell, 1(6): 584–594.
Tank JG, Pandya RV, 2022, Anti-Proliferative Activity of Surfactins on Human Cancer Cells and Their Potential Use in Therapeutics. Peptides, 155: 170836. https://linkinghub.elsevier.com/retrieve/pii/ S0196978122001024
Sur VP, Sen MK, Komrskova K, 2021, In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease. Molecules, 26(20): 6199. https://www.mdpi.com/1420-3049/26/20/6199
Uddin KM, Hosen MA, Khan MF, et al., 2022, Investigation of Structural, Physicochemical, Pharmacokinetics, PASS Prediction, and Molecular Docking Analysis of SARS-Cov-2 Against Methyl 6-O-Myristoyl-?-D-Glucopyranoside Derivatives. Philipp J Sci, 151: 2215–2231.
Afriza D, Suriyah WH, Ichwan SJA, 2018, In Silico Analysis of Molecular Interactions Between the Anti-Apoptotic Protein Survivin and Dentatin, Nordentatin, and Quercetin. J Phys Conf Ser, 1073: 032001. https://iopscience.iop.org/article/10.1088/1742-6596/1073/3/032001
Bhowmik A, Biswas S, Hajra S, et al., 2021, In Silico Validation of Potent Phytochemical Orientin as Inhibitor of SARS-Cov-2 Spike and Host Cell Receptor GRP78 Binding. Heliyon, 7(1): e05923. https://linkinghub.elsevier.com/retrieve/pii/S2405844021000281
Poupon A, Janin J, 2010, Analysis and Prediction of Protein Quaternary Structure. Methods Mol Biol, 609: 349–364. http://www.ncbi.nlm.nih.gov/pubmed/20221929
Biasini M, Bienert S, Waterhouse A, et al., 2014, SWISS-MODEL: Modelling Protein Tertiary and Quaternary Structure Using Evolutionary Information. Nucleic Acids Res, 42: W252–W258. http://www.ncbi.nlm.nih.gov/pubmed/24782522
Nahar M, Shishir A, Karim MM, et al., 2014, Cloning, Expression and Structure Simulation of Keratinase from Bacillus licheniformis Strain MZK05. Malaysian Journal of Microbiology, 12(2): 182–190.
Odoemelam CS, Hunter E, Simms J, et al., 2022, In Silico Ligand Docking Approaches to Characterise the Binding of Known Allosteric Modulators to the Glucagon-Like Peptide 1 Receptor and Prediction of ADME/Tox Properties. Appl Biosci, 1(2): 143–162. https://www.mdpi.com/2813-0464/1/2/10
Rajak P, Roy S, Pal AK, et al., 2021, In Silico Study Reveals Binding Potential of Rotenone at Multiple Sites of Pulmonary Surfactant Proteins: A Matter of Concern. Curr Res Toxicol, 2: 411–423. https://linkinghub.elsevier.com/retrieve/pii/S2666027X21000414
Koperuncholan M, Baskaran T, Aravindha V, 2022, In Silico Analysis and Molecular Docking Studies of Anti-HIV Ligand Baurenol Against Mutant Hiv-1 Reverse Transcriptase. Bull Environ Pharmacol Life Sci, 11(4): 76–84.
Yu W, MacKerell AD, 2017, Computer-Aided Drug Design Methods, in Antibiotics: Methods in Molecular Biology, Humana Press, New York, 85–106. https://doi.org/10.1007/978-1-4939-6634-9_5
Roche DB, McGuffin LJ, 2016, In Silico Identification and Characterization of Protein-Ligand Binding Sites, in Computational Design of Ligand Binding Proteins Methods in Molecular Biology, Humana Press, New York, 1–21. http://link.springer.com/10.1007/978-1-4939-3569-7_1
Khusro A, Aarti C, Agastian P, 2019, In Silico Modelling and Molecular Docking Insight of Bacterial Peptide for Anti-Tubercular and Anticancer Drug Designing. Trends Bioinforma, 13(1): 1–9. http://www.scialert.net/abstract/?doi=tb.2020.1.9
Li H, Leung K-S, Wong M-H, et al., 2016, Correcting the Impact of Docking Pose Generation Error on Binding Affinity Prediction. BMC Bioinformatics, 17(S11): 308. http://bmcbioinformatics.biomed central.com/articles/10.1186/s12859-016-1169-4
Vauquelin G, Packeu A, 2009, Ligands, Their Receptors and … Plasma Membranes. Mol Cell Endocrinol, 311(1–2): 1–10. https://linkinghub.elsevier.com/retrieve/pii/S0303720709003955
Nnyigide OS, Lee S-G, Hyun K, 2019, In Silico Characterization of the Binding Modes of Surfactants with Bovine Serum Albumin. Sci Rep, 9(1): 10643. https://www.nature.com/articles/s41598-019-47135-2
Pal A, Curtin JF, Kinsella GK, 2021, In Silico and In Vitro Screening for Potential Anticancer Candidates Targeting GPR120. Bioorg Med Chem Lett, 31: 127672. https://linkinghub.elsevier.com/ retrieve/pii/S0960894X20307836
Qasaymeh RM, Rotondo D, Oosthuizen CB, et al., 2019, Predictive Binding Affinity of Plant-Derived Natural Products Towards the Protein Kinase G Enzyme of Mycobacterium tuberculosis (MtPknG). Plants, 8(11): 477. https://www.mdpi.com/2223-7747/8/11/477
Parween A, 2020, Molecular Docking of Quinolone against INHA to Treat Tuberculosis. Int J Res Appl Sci Eng Technol, 8(6): 2421–2427. http://ijraset.com/fileserve.php?FID=29915